Larry Biegelsen
Stock Analyst at Wells Fargo
(3.47)
# 902
Out of 5,241 analysts
393
Total ratings
49.45%
Success rate
3.71%
Average return
Main Sectors:
Stocks Rated by Larry Biegelsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HTFL HeartFlow | Maintains: Overweight | $35 → $37 | $28.32 | +30.67% | 3 | May 15, 2026 | |
| GMED Globus Medical | Maintains: Overweight | $104 → $103 | $76.64 | +34.39% | 8 | May 8, 2026 | |
| ENOV Enovis | Maintains: Overweight | $42 → $40 | $24.29 | +64.68% | 1 | May 8, 2026 | |
| TFX Teleflex | Maintains: Equal-Weight | $130 → $138 | $129.71 | +6.39% | 11 | May 8, 2026 | |
| ATEC Alphatec Holdings | Maintains: Overweight | $28 → $14 | $7.66 | +82.77% | 1 | May 7, 2026 | |
| RXST RxSight | Maintains: Equal-Weight | $11 → $9 | $5.68 | +58.45% | 17 | May 7, 2026 | |
| ALC Alcon | Maintains: Overweight | $97 → $86 | $63.64 | +35.14% | 11 | May 7, 2026 | |
| SOLV Solventum | Maintains: Equal-Weight | $83 → $70 | $74.26 | -5.74% | 1 | May 6, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $12 → $15 | $14.10 | +6.38% | 3 | May 6, 2026 | |
| INSP Inspire Medical Systems | Maintains: Equal-Weight | $70 → $56 | $40.05 | +39.83% | 17 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $17 | $17.58 | -3.30% | 19 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $456 → $418 | $306.76 | +36.26% | 18 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $42 → $39 | $35.49 | +9.89% | 1 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $74 | $61.31 | +20.70% | 14 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $135 → $138 | $144.01 | -4.17% | 19 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $97 → $75 | $60.76 | +23.44% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $38 | $40.99 | -7.29% | 2 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $98 → $90 | $83.70 | +7.53% | 12 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $94 → $75 | $52.68 | +42.37% | 17 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $240 → $263 | $226.71 | +16.01% | 16 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $26 | $10.80 | +140.74% | 1 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $16 | $7.24 | +120.99% | 1 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $18 | $16.09 | +11.87% | 10 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $85 | $61.63 | +37.92% | 11 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $96 → $100 | $81.38 | +22.88% | 19 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $374 | $322.32 | +16.03% | 20 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $27 → $28 | $19.82 | +41.27% | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $72 → $82 | $59.61 | +37.56% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $114 | $76.15 | +49.70% | 19 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $13 → $14 | $12.82 | +9.20% | 11 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $599 → $600 | $421.12 | +42.48% | 21 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $0.68 → $0.85 | $1.55 | -45.16% | 6 | Aug 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $3 | $1.27 | +136.22% | 7 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $24 | $17.30 | +38.73% | 17 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $13 → $17 | $15.36 | +10.68% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $136 | $84.47 | +61.00% | 21 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $270 | $143.47 | +88.19% | 5 | Apr 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $93.91 | - | 2 | Nov 2, 2017 |
HeartFlow
May 15, 2026
Maintains: Overweight
Price Target: $35 → $37
Current: $28.32
Upside: +30.67%
Globus Medical
May 8, 2026
Maintains: Overweight
Price Target: $104 → $103
Current: $76.64
Upside: +34.39%
Enovis
May 8, 2026
Maintains: Overweight
Price Target: $42 → $40
Current: $24.29
Upside: +64.68%
Teleflex
May 8, 2026
Maintains: Equal-Weight
Price Target: $130 → $138
Current: $129.71
Upside: +6.39%
Alphatec Holdings
May 7, 2026
Maintains: Overweight
Price Target: $28 → $14
Current: $7.66
Upside: +82.77%
RxSight
May 7, 2026
Maintains: Equal-Weight
Price Target: $11 → $9
Current: $5.68
Upside: +58.45%
Alcon
May 7, 2026
Maintains: Overweight
Price Target: $97 → $86
Current: $63.64
Upside: +35.14%
Solventum
May 6, 2026
Maintains: Equal-Weight
Price Target: $83 → $70
Current: $74.26
Upside: -5.74%
Integra LifeSciences Holdings
May 6, 2026
Maintains: Equal-Weight
Price Target: $12 → $15
Current: $14.10
Upside: +6.38%
Inspire Medical Systems
May 5, 2026
Maintains: Equal-Weight
Price Target: $70 → $56
Current: $40.05
Upside: +39.83%
May 4, 2026
Maintains: Equal-Weight
Price Target: $14 → $17
Current: $17.58
Upside: -3.30%
May 1, 2026
Maintains: Overweight
Price Target: $456 → $418
Current: $306.76
Upside: +36.26%
May 1, 2026
Maintains: Equal-Weight
Price Target: $42 → $39
Current: $35.49
Upside: +9.89%
May 1, 2026
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $61.31
Upside: +20.70%
Apr 30, 2026
Maintains: Overweight
Price Target: $135 → $138
Current: $144.01
Upside: -4.17%
Apr 30, 2026
Maintains: Overweight
Price Target: $97 → $75
Current: $60.76
Upside: +23.44%
Apr 29, 2026
Maintains: Overweight
Price Target: $40 → $38
Current: $40.99
Upside: -7.29%
Apr 29, 2026
Maintains: Equal-Weight
Price Target: $98 → $90
Current: $83.70
Upside: +7.53%
Apr 23, 2026
Maintains: Overweight
Price Target: $94 → $75
Current: $52.68
Upside: +42.37%
Apr 15, 2026
Maintains: Overweight
Price Target: $240 → $263
Current: $226.71
Upside: +16.01%
Mar 31, 2026
Initiates: Overweight
Price Target: $26
Current: $10.80
Upside: +140.74%
Mar 11, 2026
Initiates: Overweight
Price Target: $16
Current: $7.24
Upside: +120.99%
Feb 19, 2026
Maintains: Equal-Weight
Price Target: $17 → $18
Current: $16.09
Upside: +11.87%
Feb 13, 2026
Maintains: Overweight
Price Target: $93 → $85
Current: $61.63
Upside: +37.92%
Feb 11, 2026
Maintains: Overweight
Price Target: $96 → $100
Current: $81.38
Upside: +22.88%
Jan 15, 2026
Downgrades: Equal-Weight
Price Target: $374
Current: $322.32
Upside: +16.03%
Dec 12, 2025
Maintains: Overweight
Price Target: $27 → $28
Current: $19.82
Upside: +41.27%
Dec 5, 2025
Maintains: Equal-Weight
Price Target: $72 → $82
Current: $59.61
Upside: +37.56%
Nov 19, 2025
Maintains: Overweight
Price Target: $100 → $114
Current: $76.15
Upside: +49.70%
Nov 7, 2025
Maintains: Equal-Weight
Price Target: $13 → $14
Current: $12.82
Upside: +9.20%
Oct 22, 2025
Maintains: Overweight
Price Target: $599 → $600
Current: $421.12
Upside: +42.48%
Aug 15, 2025
Maintains: Equal-Weight
Price Target: $0.68 → $0.85
Current: $1.55
Upside: -45.16%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $6 → $3
Current: $1.27
Upside: +136.22%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $33 → $24
Current: $17.30
Upside: +38.73%
Jan 30, 2025
Maintains: Overweight
Price Target: $13 → $17
Current: $15.36
Upside: +10.68%
Apr 5, 2023
Maintains: Overweight
Price Target: $140 → $136
Current: $84.47
Upside: +61.00%
Apr 8, 2020
Maintains: Overweight
Price Target: $279 → $270
Current: $143.47
Upside: +88.19%
Nov 2, 2017
Upgrades: Outperform
Price Target: n/a
Current: $93.91
Upside: -